ICCC

ImmuCell (ICCC)

About ImmuCell (ICCC)

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

Details

Daily high

$6.19

Daily low

$5.95

Price at open

$6.03

52 Week High

$7.60

52 Week Low

$4.28

Market cap

54.0M

Dividend yield

0.00%

Volume

8,795

Avg. volume

15,313

P/E ratio

23.06

ImmuCell News